Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface

Leukemia Research

Volumn 31, Issue 11, 2007, Pages 1461-1468

  Wimazal, Friedrich ^a   Fonatsch, Christa ^a   Thalhammer, Renate ^a   Schwarzinger, Ilse ^a   Müllauer, Leonhard ^a   Sperr, Wolfgang R ^a   Bennett, John M ^b   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

FISH; Karyotyping; Minimal criteria; Myelodysplastic syndromes

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW CELL; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CYTOPENIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE; KARYOTYPING; MALE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 35448974513     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.03.015     Document Type: Article

References (23)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
2. Kouides P.A., and Bennett J.M. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 33 (1996) 95-110
3. Brunning R.D., Bennett J.M., Flandrin G., Matutes E., Head D., Vardiman J.W., et al. Myelodysplastic syndromes. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World health organization classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues vol. 1 (2001), IARC Press, Lyon 61-73
4. Valent P., Horny H.-P., Bennett J.M., Fonatsch C., Germing U., Greenberg P., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes. Consensus Statements and Report from a Working Conference. Leuk Res 31 (2007) 727-736
5. Kuriyama K., Tomonaga M., Matsuo T., Ginnai I., and Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micromegakaryocytes in myelodysplastic syndrome. Br J Haematol 63 (1986) 665-669
6. Tennant G.B., Jacobs A., and Bailey-Wood R. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes. Exp Hematol 14 (1986) 1063-1068
7. Geissler K., Hinterberger W., Jager U., Bettelheim P., Neumann E., Haas O., et al. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes. Blut 57 (1988) 45-49
8. Shih L.Y., Chiu W.F., and Lee C.T. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome. Leukemia 5 (1991) 1092-1098
9. Berer A., Jager E., Sagaster V., Streubel B., Wimazal F., Sperr W.R., et al. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes. Ann Hematol 82 (2003) 271-277
10. Steidl C., Steffens R., Gassmann W., Hildebrandt B., Hilgers R., Germing U., et al. Adequate cytogenetic examination in myelodysplastic syndromes: analysis of 529 patients. Leuk Res 29 (2005) 987-993
11. Haase D., Fonatsch C., Freund M., Wormann B., Bodenstein H., Bartels H., et al. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 70 (1995) 171-187
12. Schaffer LG, Tommerup N, Karger S, editors. ISCN-An international system for human cytogenetic nomenclature. Switzerland: Basel; 2005.
13. Cherry A.M., Brockman S.R., Paternoster S.F., Hicks G.A., Neuberg D., Higgins R.R., et al. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leuk Res 27 (2003) 1085-1090
14. Bernasconi P., Cavigliano P.M., Boni M., Calatroni S., Klersy C., Giardini I., et al. Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia 17 (2003) 2107-2112
15. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 (2002) 3887-3896
16. Wells D.A., Benesch M., Loken M.R., Vallejo C., Myerson D., Leisenring W.M., et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102 (2003) 394-403
17. Benesch M., Deeg H.J., Wells D., and Loken M. Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes. Hematology 9 (2004) 171-177
18. Ogata K., Kishikawa Y., Satoh C., Tamura H., Dan K., and Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 108 (2006) 1037-1044
19. Babicka L., Ransdorfova S., Brezinova J., Zemanova Z., Sindelarova L., Siskova M., et al. Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH. Leuk Res 31 (2007) 39-47
20. Hofmann W.K., de Vos S., Komor M., Hoelzer D., Wachsman W., and Koeffler H.P. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100 (2002) 3553-3560
21. Pellagatti A., Esoof N., Watkins F., Langford C.F., Vetrie D., Campbell L.J., et al. Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Br J Haematol 125 (2004) 576-583
22. Cutler C.S., Lee S.J., Greenberg P., Deeg H.J., Perez W.S., Anasetti C., et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 104 (2004) 579-585
23. Deeg H.J. Optimization of transplant regimens for patients with myelodysplastic syndrome (MDS). Hematol Am Soc Hematol Educ Progr (2005) 167-173